In Brief: House Oversight & Investigation Subcommittee
Executive Summary
House Oversight & Investigation Subcommittee: FDA lead deputy commissioner Michael Friedman, MD, scheduled to testify about FDA compassionate use programs before the subcommittee Sept. 23. Agenda describes Friedman as the "leading candidate to be the next FDA Commissioner." He will appear with patients and Houston attorney Richard Jaffe, who has represented antineoplaston researcher Stanislaw Burzynski, MD...